VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Novel approaches in newly diagnosed myeloma

Philippe Moreau, MD, of Nantes University Hospital, Nantes, France, explores new strategies for newly diagnosed multiple myeloma (MM) patients. Specifically discussed are results from the Phase III MAIA study (NCT02252172) as well as the use of daratumumab in transplant-eligible patients per the CASSIOPEIA trial (NCT02541383). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter